These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21566548)

  • 1. Double blind clinical trial in a series of 115 patients with seborrheic dermatitis: prevention of relapses using a topical modulator of Toll like receptor 2.
    Ionescu MA; Baroni A; Brambilla L; Cannavò SP; Cristaudo A; Vedove CD; Frasca M; Girolomoni G; Gnecchi L; Peris K; Trifirò C; Matta AM; Robert G
    G Ital Dermatol Venereol; 2011 Jun; 146(3):185-9. PubMed ID: 21566548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
    Diehl C; Ferrari A
    J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent.
    Piérard GE; Ausma J; Henry F; Vroome V; Wouters L; Borgers M; Cauwenbergh G; Piérard-Franchimont C
    Dermatology; 2007; 214(2):162-9. PubMed ID: 17341867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
    Shuster S; Meynadier J; Kerl H; Nolting S
    Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial.
    Kim TW; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim MB; Song KH; Lee SK; Seo JK; Lee D; Kim BS
    Acta Derm Venereol; 2013 Sep; 93(5):557-61. PubMed ID: 23388687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
    Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
    Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
    Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
    Lebwohl M; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.
    Gupta AK; Versteeg SG
    Am J Clin Dermatol; 2017 Apr; 18(2):193-213. PubMed ID: 27804089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
    Abeck D;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():13-6. PubMed ID: 15271195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
    Ozden MG; Tekin NS; Ilter N; Ankarali H
    Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis.
    Ballanger F; Tenaud I; Volteau C; Khammari A; Dréno B
    Arch Dermatol Res; 2008 Jun; 300(5):215-23. PubMed ID: 18330588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis.
    Elewski BE; Cantrell WC
    J Drugs Dermatol; 2011 Aug; 10(8):895-9. PubMed ID: 21818511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
    Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
    J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seborrheic dermatitis of the scalp: etiology and treatment.
    Gupta AK; Nicol KA
    J Drugs Dermatol; 2004; 3(2):155-8. PubMed ID: 15098970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with repetitive use of pimecrolimus: exploring the effective and safe use in the treatment of relapsing seborrheic dermatitis.
    Tatlican S; Eren C; Oktay B; Eskioglu F; Durmazlar PK
    J Dermatolog Treat; 2010 Mar; 21(2):83-5. PubMed ID: 19391059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.